Ystem S.r.l. started out its activity in May 2012 as a spin-off belonging to the University of Milan.
Ystem know-how moves from its scientific board expertise within Regenerative Medicine and the use of stem cell as therapy for neurodegenerative disorders. Background is marked by several publications in international peer-reviewed journals as well as important commitment in clinical studies about muscular tissue regeneration: among them, our scientists have been involved in clinical trials about the validation of stem cell transplantation in dystrophic patients and treatments for nerve restoration.
Besides the academic and clinical outstanding experience, Ystem avails itself of managerial-skilled associates with a pre-existing background in Life Sciences, whose contribution gives a crucial entrepreneurial orientation to the company and a further value to the company supply.